Podcast PX Pulse

Three Perspectives, Two Trials and One Big Goal

February 26, 2018

With more efficacy trials underway today than ever before in HIV prevention research, this episode of Px Pulse zooms in on two that have most recently launched: one of two trials testing a long-acting injectable antiretroviral called cabotegravir (HPTN 084), and the study of a “mosaic” vaccine developed by Janssen Pharmaceuticals (HVTN 705/HPX2008).

Subscribe to this Podcast

Tracking and Translating the Field